NextFin News - A collaborative study released on February 3, 2026, by researchers from Harvard, Michigan, and Duke universities has ignited a global policy debate by asserting that ultra-processed foods (UPFs) share more structural and behavioral commonalities with cigarettes than with traditional food groups. Published in the medical journal Milbank Quarterly, the research details how industrial food processing has evolved to create products that bypass natural satiety signals, driving compulsive consumption patterns similar to nicotine addiction. The study comes at a critical juncture as U.S. President Trump’s administration faces increasing pressure to address rising healthcare costs associated with metabolic diseases, which now account for a significant portion of federal health spending.
The research team, led by Ashley Gearhardt, a professor of psychology at the University of Michigan, utilized data from addiction science, nutrition, and public health history to demonstrate that UPFs—ranging from sugary cereals to frozen pizzas—are optimized for "hedonic impact." According to Gearhardt, these products are engineered to deliver rapid doses of refined carbohydrates and fats, which trigger dopamine releases in the brain's reward circuits. The study highlights that the food industry often employs "health washing" tactics, such as labeling products as "low-fat" or "sugar-free," which the researchers compare to the tobacco industry’s promotion of "light" or filtered cigarettes in the 1950s to delay regulatory oversight.
The economic and public health implications of these findings are profound. In the United States, UPFs currently account for more than 50% of the average daily caloric intake, while in the United Kingdom, that figure rises to nearly two-thirds for adolescents. According to the World Health Organization (WHO), diets high in UPFs are directly linked to increased risks of heart disease, type 2 diabetes, and certain cancers. The study argues that because these foods are industrially re-engineered from natural substances to maximize profit and palatability, they should be regulated as addictive substances rather than mere nutrients. This would shift the burden of responsibility from individual willpower to corporate accountability, mirroring the legal framework that eventually curtailed the tobacco epidemic.
From a regulatory perspective, the transition from tobacco-style oversight to the food industry involves several complex mechanisms. The researchers propose a multi-tiered policy framework: implementing excise taxes on nutrient-poor UPFs, restricting marketing directed at children, and mandating front-of-pack warning labels. Such measures have already seen preliminary success in countries like Chile and Mexico, where high-sugar and high-sodium warnings led to a measurable shift in consumer behavior. However, the study acknowledges a key difference: while tobacco is entirely discretionary, food is essential. This distinction, Gearhardt argues, makes regulation even more urgent, as consumers cannot easily "opt out" of a modern food environment dominated by engineered products.
The financial sector is already beginning to price in these regulatory risks. Analysts suggest that if tobacco-style litigation or taxation were applied to major food and beverage conglomerates, it could lead to significant valuation adjustments. The "Big Food" industry currently faces a landscape similar to "Big Tobacco" in the late 20th century, where scientific consensus on harm eventually overrode industry lobbying. Forward-looking trends suggest that as healthcare systems buckle under the weight of chronic disease, governments may increasingly view UPF regulation not just as a health initiative, but as a fiscal necessity to preserve national productivity and reduce the long-term liabilities of public health programs.
As the debate intensifies, the focus is expected to shift toward defining precise pharmacological thresholds for food addiction. While some critics, such as Martin Warren of the Quadram Institute, argue that the comparison to nicotine may be overstated, the momentum for structural intervention is growing. The next phase of this policy evolution will likely involve a battle over "industrial design" standards, where regulators may seek to limit the specific combinations of additives and processing techniques that make UPFs uniquely addictive. For U.S. President Trump and other global leaders, the challenge will be balancing the economic interests of a massive industrial sector against the escalating costs of a public health crisis that shows no signs of abating without systemic change.
Explore more exclusive insights at nextfin.ai.
